Medindia

X

Dr Reddy’s Launches Cheaper Version of Antibiotic Avelox in US

by Anubha Sinha on  March 6, 2014 at 6:07 PM Drug News   - G J E 4
Dr Reddy's Laboratories said that after a nod from United States Food & Drug Administration (USFDA) it has launched Moxifloxacin Hydrochloride Tablets 400 mg in the US.
 Dr Reddy’s Launches Cheaper Version of Antibiotic Avelox in US
Dr Reddy’s Launches Cheaper Version of Antibiotic Avelox in US
Advertisement

In the US, Moxifloxacin will be the cheaper version of antibiotic drug Avelox, which is manufactured by Bayer AG and distributed by Merck. The other two firms with approval of this drug are Teva and Aurobindo Pharma.

Advertisement
According to IMS Health, for the year ending December 2013 Avelox brand had US sales of approximately $195 mn.

Last week, Dr Reddy's Laboratories launched anti-migraine sumatriptan injection in the US which clocked $169-million sales in 2013.

Moxifloxacin is an antibiotic which is used for treating acute bacterial sinusitis, bronchitis, skin and abdominal infections.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All